Drug intelligence / Profile preview

sulfamerazine

Development stage
Discontinued
Modality
Small Molecules
Administration
Oral
01

Overview

Sulfamerazine is a small molecule sulfonamide antibiotic used primarily for the treatment of various bacterial infections, including bronchitis, prostatitis, and urinary tract infections. It acts as a bacteriostatic agent by inhibiting the bacterial enzyme dihydropteroate synthase (also known as dihydrofolate synthetase), which is essential for folic acid synthesis in bacteria. By competing with para-aminobenzoic acid (PABA) for binding to this enzyme, sulfamerazine disrupts the production of dihydrofolic acid and subsequently impairs nucleic acid and DNA synthesis in susceptible organisms. Sulfamerazine has been approved for both human and veterinary use but is no longer available for human use in some regions such as the United States[1][2][5][6][8].

Brand names
Neotrizine
Other names
sulfamerazine4-amino-N-(4-methyl-2-pyrimidinyl)benzenesulfonamide
02

Targets

DHPS (Dihydropteroate synthase)

Beyond the preview

Go deeper on sulfamerazine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sulfamerazine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call